| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.78 | 0.003 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.008 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.081 | 0.009 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |